95
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

Venlafaxine in the treatment of anxiety disorders

Pages 371-381 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H. Parmentier, J. García-Campayo & R. Prieto. (2013) Comprehensive review of generalized anxiety disorder in primary care in Europe. Current Medical Research and Opinion 29:4, pages 355-367.
Read now

Articles from other publishers (11)

André Acácio Souza da Silva, Fabiane de Santi, Barry T. Hinton, Paulo Sérgio Cerri & Estela Sasso-Cerri. (2023) Venlafaxine increases aromatization, reduces apical V-ATPase in clear cells and induces increased number of mast cells and smooth muscle cells death in rat cauda epididymis. Life Sciences 315, pages 121329.
Crossref
Fabiane Santi, Flávia L. Beltrame, Beatriz M. Rodrigues, Marcio J. V. P. Junior, Natália F. Scaramele, Flávia L. Lopes, Paulo S. Cerri & Estela Sasso‐Cerri. (2020) Venlafaxine‐induced damage to seminiferous epithelium, spermiation, and sperm parameters in rats: A correlation with high estrogen levels. Andrology 9:1, pages 297-311.
Crossref
Ana Luísa Maulvault, Lúcia H.M.L.M. Santos, José Ricardo Paula, Carolina Camacho, Vasco Pissarra, Fabiola Fogaça, Vera Barbosa, Ricardo Alves, Pedro Pousão Ferreira, Damià Barceló, Sara Rodriguez-Mozaz, António Marques, Mário Diniz & Rui Rosa. (2018) Differential behavioural responses to venlafaxine exposure route, warming and acidification in juvenile fish (Argyrosomus regius). Science of The Total Environment 634, pages 1136-1147.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 111 143 .
Caroline T. Nguyen, Michael I. MacEntee, Barbara Mintzes & Thomas L. Perry. (2013) Information for Physicians and Pharmacists About Drugs That Might Cause Dry Mouth: A Study of Monographs and Published Literature. Drugs & Aging 31:1, pages 55-65.
Crossref
Bernardo Dell’Osso, M. Carlotta Palazzo, Lucio Oldani & A. Carlo Altamura. (2011) The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects. CNS Neuroscience & Therapeutics 17:6, pages 723-732.
Crossref
Magid Abou-Gharbia & Wayne E. ChildersJr.Jr.. 2010. Analogue-Based Drug Discovery II. Analogue-Based Drug Discovery II 507 524 .
Hartmut Lüddens & Klaus Wiedemann. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 627 641 .
Carola Stiglmayr, Christian Stiglmayr, Susanne Jerschke & Kirsten Schehr. (2006) Zum Krankheitsbild der generalisierten Angststörung aus heutiger Sicht. Verhaltenstherapie 16:1, pages 51-57.
Crossref
David J. Nutt & Dan J. Stein. (2014) Understanding the Neurobiology of Comorbidity in Anxiety Disorders. CNS Spectrums 11:S12, pages 13-20.
Crossref
Michihiko Iijima & Shigeyuki Chaki. (2005) Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization. Pharmacology Biochemistry and Behavior 82:4, pages 652-657.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.